Literature DB >> 18992322

Generations of sequencing technologies.

Erik Pettersson1, Joakim Lundeberg, Afshin Ahmadian.   

Abstract

Advancements in the field of DNA sequencing are changing the scientific horizon and promising an era of personalized medicine for elevated human health. Although platforms are improving at the rate of Moore's Law, thereby reducing the sequencing costs by a factor of two or three each year, we find ourselves at a point in history where individual genomes are starting to appear but where the cost is still too high for routine sequencing of whole genomes. These needs will be met by miniaturized and parallelized platforms that allow a lower sample and template consumption thereby increasing speed and reducing costs. Current massively parallel, state-of-the-art systems are providing significantly improved throughput over Sanger systems and future single-molecule approaches will continue the exponential improvements in the field.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18992322     DOI: 10.1016/j.ygeno.2008.10.003

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  81 in total

Review 1.  Clinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challenges.

Authors:  Laura E MacConaill; Paul Van Hummelen; Matthew Meyerson; William C Hahn
Journal:  Cancer Discov       Date:  2011-09       Impact factor: 39.397

2.  Nanotechnology for energy-based cancer therapies.

Authors:  Kyle Gilstrap; Xiaoxiao Hu; Xiongbin Lu; Xiaoming He
Journal:  Am J Cancer Res       Date:  2011-03-11       Impact factor: 6.166

3.  High-resolution typing by integration of genome sequencing data in a large tuberculosis cluster.

Authors:  Anita C Schürch; Kristin Kremer; Olaf Daviena; Albert Kiers; Martin J Boeree; Roland J Siezen; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

Review 4.  Single-cell and regional gene expression analysis in Alzheimer's disease.

Authors:  Ruby Kwong; Michelle K Lupton; Michal Janitz
Journal:  Cell Mol Neurobiol       Date:  2012-01-22       Impact factor: 5.046

Review 5.  Genome-wide association studies of sleep disorders.

Authors:  David M Raizen; Mark N Wu
Journal:  Chest       Date:  2011-02       Impact factor: 9.410

6.  The impact of whole genome sequencing on model system genetics: get ready for the ride.

Authors:  Oliver Hobert
Journal:  Genetics       Date:  2010-02       Impact factor: 4.562

Review 7.  Making sense of cancer genomic data.

Authors:  Lynda Chin; William C Hahn; Gad Getz; Matthew Meyerson
Journal:  Genes Dev       Date:  2011-03-15       Impact factor: 11.361

Review 8.  Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes.

Authors:  Altin Gjymishka; Roxana M Coman; Todd M Brusko; Sarah C Glover
Journal:  Immunotherapy       Date:  2013-12       Impact factor: 4.196

Review 9.  DNA methylation of cancer genome.

Authors:  Hoi-Hung Cheung; Tin-Lap Lee; Owen M Rennert; Wai-Yee Chan
Journal:  Birth Defects Res C Embryo Today       Date:  2009-12

10.  Increased throughput by parallelization of library preparation for massive sequencing.

Authors:  Sverker Lundin; Henrik Stranneheim; Erik Pettersson; Daniel Klevebring; Joakim Lundeberg
Journal:  PLoS One       Date:  2010-04-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.